Winner of 2010 Anatrace Membrane Protein Award

NewsGuard 100/100 Score

Affymetrix, Inc. (Nasdaq: AFFX) today announced that Professor Tom Rapoport of Harvard Medical School and Howard Hughes Medical Institute is the winner of the 2010 Anatrace Membrane Protein Award. The award was presented at the Biophysical Society annual meeting in San Francisco and is sponsored by Anatrace, which is now part of Affymetrix.

“Part of our mission is to deliver highly purified reagents to further scientific discovery. We are honored to be able to recognize Professor Rapoport’s work and to be a part of his research.”

The Anatrace Membrane Protein Award recognizes the scientist who has made the most outstanding contribution to understanding the structure or function of membrane proteins. Professor Rapoport’s work has clarified the mechanism by which proteins cross membranes and is the first to determine the structure of a protein-conducting channel.

The Rapoport group has also addressed how incorrectly folded proteins are transported through a membrane for cytosolic degradation, an important process in many diseases, and the mechanism by which the characteristic shape of an organelle is achieved. All of these projects concern fundamental aspects of membrane biology.

Tom Rapoport was elected to the National Academy of Sciences in 2005 and has spent much of his career studying protein translocation and other aspects of membrane biology. His laboratory has published many articles in leading journals, often using Anatrace products from Affymetrix.

“Professor Rapoport’s work clarifying the role of structure in protein function is an important finding as we seek to better understand the onset of disease,” said Kristin Yakimow, senior vice president and general manager of Affymetrix reagents. “Part of our mission is to deliver highly purified reagents to further scientific discovery. We are honored to be able to recognize Professor Rapoport’s work and to be a part of his research.”

Source: Affymetrix, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-powered method predicts protein dynamics to accelerate drug discovery